Pneumothorax in a patient with pneumonia caused by SARS-CoV-2: A case report
Abstract
Uvod. Koronavirusna bolest 2019 (COVID-19) je akutna, infektivna multisistemska bolest koja se najčešće manifestuje akutnim respiratornim simptomima. Izaziva je severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Nova koronavirusna pneumonija (NCP) je najčešća ozbiljna klinička manifestacija SARS-CoV-2 infekcije. U teškoj NCP ispoljene su i sistemske manifestacije bolesti, a jedna od retkih komplikacija, prvi put opisana u Vuhanu (Kina), je pneumotoraks. Prikaz bolesnika. Bolesnica stara 65 godina primljena je u Kliniku za pulmologiju zbog febrilnosti, otežanog disanja, gušobolje i opšte malaksalosti koje je imala prethodnih 5 dana. Laboratorijskim ispitivanjem otkriveni su limfopenija, povišene vrednosti parametara zapaljenja i lezija jetre. Radiografijom (RDG) grudnog koša utvrđeno je difuzno naglašen intersticijum i smanjena transparencija parenhima levo perihilarno. Prisustvo SARS-CoV-2 u uzorku nazofaringealnog brisa otkriveno je lančanom reakcijom polimeraze (PCR), čime je potvrđena dijagnoza NCP. Odmah je započeta terapija kiseonikom preko nazalne kanile protoka 8 L/min, uz hlorokin fosfat, antibiotike i simptomatsku terapiju. Osmog dana, stanje bolesnice se naglo pogoršalo i razvila je tešku hipoksemiju. Ponovljenom RDG grudnog koša potvrđen je kompletan pneumotoraks levo. Torakalna drenaža je uspešno izvedena uz potpunu reekspanziju pluća već sledećeg dana. Bolesnica je otpuštena iz bolnice u dobrom opštem stanju, sa normalnim gasovima arterijske krvi. Zaključak. Usled oštećenja alveola, pneumotoraks kao komplikacija pneumonije izazvane SARS-CoV-2, može nastati bez prethodnih plućnih oboljenja. Akutno pogoršanje sa naglom desaturacijom kiseonikom kod tih bolesnika trebalo bi da pobudi sumnju na pneumotoraks. Rana dijagnoza i brzo lečenje su neophodni za smanjenje smrtnosti.
References
World Health Organization WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. Geneva: World Health Organization, 2020. Available from: (https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020). [accessed 2020 March 29].
Oran DP, Topol EJ. Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review. Ann Intern Med 2020; 173(5): 362‒7.
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Preven-tion. JAMA 2020; 323(13): 1239–42.
Yao W, Wang T, Jiang B, Gao F, Wang L, Zheng H, et al. Emer-gency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recom-mendations. Br J Anaesth 2020; 125(1): e28‒e37.
Aydin S, Ӧz G, Dumanli A, Balci A, Gencer A. A Case of Spon-taneous Pneumothorax in Covid-19 Pneumonia. J Surg Res 2020; 3(2): 96–101.
Mallick T, Dinesh A, Engdahl R, Sabado M. COVID-19 Com-plicated by Spontaneous Pneumothorax. Cureus 2020; 12(7): e9104.
Ucpinar BA, Sahin C, Yanc U. Spontaneous pneumothorax and subcutaneous emphysema in COVID-19 patient: Case re-port. J Infect Public Health 2020; 13(6): 887‒9.
González-Pacheco H, Gopar-Nieto R, Jiménez-Rodríguez GM, Man-zur-Sandoval D, Sandoval J, Arias-Mendoza A. Bilateral sponta-neous pneumothorax in SARS-CoV-2 infection: A very rare, life-threatening complication. Am J Emerg Med 2021; 39: 258.e1–258.e3.
Sun R, Liu H, Wang X. Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia. Korean J Radiol 2020; 21(5): 541‒4.
Rohailla S, Ahmed N, Gough K. SARS-CoV-2 infection associ-ated with spontaneous pneumothorax. CMAJ 2020; 192(19): E510.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020; 323(11): 1061‒9.
Barreto HG, de Pádua Milagres FA, de Araújo GC, Daúde MM, Benedito VA. Diagnosing the novel SARS-CoV-2 by quantita-tive RT-PCR: variations and opportunities. J Mol Med (Berl) 2020; 98(12): 1727‒36.
Chen N, Zhou M, Dong X, Qu, J, Gong F, Han Y, et al. Epide-miological and clinical characteristics of 99 cases of 2019 nov-el coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507‒13.
Noppen M. Spontaneous pneumothorax: epidemiology, patho-physiology and cause. Eur Respir Rev 2010; 19(117): 217‒9.
Liu K, Zeng Y, Xie P, Ye X, Xu G, Liu J, et al. COVID-19 with cystic features on computed tomography: A case re-port. Medicine (Baltimore) 2020; 99(18): e20175.
Zhu N, Wang W, Liu Z, Liang C, Wang W, Ye F, et al. Mor-phogenesis and cytopathic effect of SARSCoV-2 infection in human airway epithelial cells. Nat Commun 2020; 11(1): 3910.
Xiang C, Wu G. SARS-CoV-2 pneumonia with subcutaneous emphysema, mediastinal emphysema, and pneumothorax: A case report. Medicine (Baltimore) 2020; 99(20): e20208.
Al-Shokri SD, Ahmed AOE, Saleh AO, AbouKamar M, Ahmed K, Mohamed MFH. Case Report: COVID-19-Related Pneumo-thorax-Case Series Highlighting a Significant Complica-tion. Am J Trop Med Hyg 2020; 103(3): 1166‒9.
Alhakeem A, Khan MM, Al Soub H, Yousaf Z. Case Report: COVID-19-Associated Bilateral Spontaneous Pneumothorax-A Literature Review. Am J Trop Med Hyg 2020; 103(3): 1162‒5.